dosimetric equipment, e.g., thermoluminescent detectors (TLDs) [1] , [2] , diodes [1] and MOSFETS [2] to be extended to the limits of their capability. In the case of the former, it is not possible to use TLDs for real-time measurement and so these devices only allow for measurement post irradiation. Diodes and MOSFETS are capable of measurement in real-time, but require significant "build up" (packaging) before use in the beam and require regular recalibration as the received dose alters the sensitivity characteristics of the devices. Ionisation chambers (ICs) are highly accurate devices that are widely used in quality assurance (QA) in external beam radiotherapy (EBRT) based systems and they are capable of real-time measurements of the cumulative dose. However, they rely on a vacuum chamber with an applied potential difference that can be in the 10 s of volts range or even higher. This prohibits its use in-vivo. Recent developments in treatment options include the use of protons and heavy ions, and these provide additional scope for novel dosimetric systems.
There are commonly agreed Codes of Practice which define how the dosimetric calibration of treatment beams should be performed [3] . In addition to calibration dosimetry, it is also possible to monitor the dose delivery during treatment (in-vivo), however this can currently only be achieved by measuring the dose at a "surrogate" position, usually on the patient's skin surface, rather than directly within the tumour itself. At present there is no available technique for directly measuring, in realtime, the treatment dose within the tumour itself. The sensor described herein allows the monitoring of real-time dose delivery to the extent that the individual X-Ray pulses from linear accelerators (Linacs) can be discriminated.
A dosimeter can be defined generally as any device that is capable of providing an output value that is a measure of the average absorbed dose deposited in its sensitive volume by ionizing radiation. In the case of a photon beam in EBRT, absorption of energy takes place from the beam and this is imparted to the scintillator material, which in turn emits visible light that is ultimately detected using opto-electronic conversion, in this case using an avalanche photodetector (APD) array. Typically, X-Ray scintillator materials are characterized by a rapid decay time, being of the order of a few 10 s of nanoseconds [4] Radiation dosimetry deals with methods for a quantitative determination of the energy deposited in a given medium by direct or indirect ionizing radiation. Radiation induced optical attenuation [5] , [6] or using the detection of Cerenkov radiation/fluorescence/radioluminescence [7] [8] [9] , or extrinsic optical fibre technology, employing different ionizing radiation to optical radiation convertors [10] [11] [12] , has been the focus of much research in recent years. Many different types of light scintillating materials as well as many different methods of using these materials have been widely published [13] [14] [15] [16] [17] . Recently, the growth of dosimeters based on plastic optical fibres (POF) technology was registered, supported by the benefits of using polymethyl-methacrylate (PMMA) plastic type optical fibres. The use of optical fibres as sensors in dosimetry was recently comprehensively reviewed by O'Keeffe et al. [18] . In addition to having the capability of real time measurement, other benefits of this type of technology are: simple installation and usage, immunity to external electromagnetic interference, increased security and lower associated tooling and general costs of fabrication. The research described in this article is focused towards the biomedical industry and in particular, towards the real-time radiation measurement in EBRT applications.
II. SENSOR AND SYSTEM DESIGN
The principle of the fibre optic dosimeter described in this paper relies on the conversion (by fluorescence) of the incident radiation dose rate to a measurable optical signal in the visible wavelength range (548 nm) and the principle of operation has been described in [19] . The sensor design of McCarthy et al. [19] , which involved coating the tip of a PMMA fibre with scintillation doped epoxy, was modified for the purpose of this investigation to allow for improved coupling of the radioluminescence signal and improved reproducibility and potential manufacturability. The end of the 1-mm PMMA fibre optic core was micro-machined to create a small hole (diameter: 0.25 to 0.5 mm; depth: 0.5 mm), which was filled with a mixture of epoxy and the scintillating material. The novel optical fibre sensor (OFS) design is shown in schematic form in Fig. 1(a) and photographically in (b).
As the dose rates are relatively small for clinical oncology purposes (typically 100-600\, Gy/min, delivering a typical patient dose of 2 Gy per fraction (treatment session)), the impact on the POF for light transmission is very small and such a deterioration has not been observed in several months of operation. Previous work by O'Keeffe et al. [6] has suggested that when exposed to significantly higher dose levels, e.g., in the vicinity of test nuclear reactor facilities where dose values accrued to several 100's of kGy, some attenuation was observed. However, even in these cases the fibre was still usable and demonstrated some recovery. One of the outcomes of that work suggested that for the clinical dose level the optical fibre is affected by the radiation in a very minimal way and over the expected working lifetime of the sensor this is negligible.
The scintillating material, Gadolinium Oxysulfide activated with Terbium (Gd 2 O 2 S:Tb), fluoresces when exposed to ionising radiation (X-Rays). It was obtained in powder form from Phosphor Technologies (UKL65/FR1) and its emission properties are defined in [20] . The visible optical signal generated by the scintillator propagates to the distal end of the optical fibre (30 m from the point of measurement) at which point it was detected using a Hamamatsu Multi-Pixel Photon Counter, MPPC C11208-01, APD array that was thermoelectrically cooled to allow for low light intensity detection.
The advantage of using a single channel sensitive photodetector such as the MPPC device used in this investigation is that it can be operated with a very short gate duration time (exposure time to the incoming optical signal from the optical fibre) which in this investigation was 0.1 ms. In order to achieve this, special software was written (in C++) to control the device, as the minimum gate time allowed by the manufacturer's proprietary software was 1 ms, which does not allow adequate time resolution to detect the individual pulses of the linac beam. All data acquisition and signal control were captured via the Universal Serial Bus (USB) interface of a Dell Notebook PC running the Windows 7, 32 bit operating system. All measurements were recorded on a Varian IX3937 linac at the External Radiation Beam Therapy Clinic of the First Affiliated Hospital of the Harbin Medical University, Harbin, China. The schematic of the sensor system used in the clinic and its orientation to the linac beam delivery system is shown if Fig. 2 (a) and a photograph of the sensor placed in situ in the beam path is shown in (b).
For the purpose of the tests of this investigation the OFS was immersed in a water tank and covered with water to a depth of 
III. RESULTS AND ANALYSIS
The OFS was placed in the line of the beam at the distance setting of 100 cm, representing a standard source to surface distance setting for oncology QA procedures. The sensor was submerged in water as shown in Fig. 2(b) . A PTW type TW30012-1 IC was also located in a special dry compartment in the tank (see Fig. 2(b) ), so that simultaneous and co-located measurements of dose could also be acquired. The OFS and IC were then irradiated by the linac beam from directly above (0°Gantry Rotation) with the operating conditions 6 MV (Photon Energy), 600 monitor units/min (MU/min) dose rate, for a duration of 20 s. The target cumulative dose delivered per macro-pulse at the water depth indicated in this result (15 mm) was 200 monitor units (MU), which was confirmed using the IC to be 204 MU. Fig. 3(a) shows the optical intensity (photon counts) for two consecutive macro-pulses of beam radiation, over a duration of 20 s, which are separated by an approximate period of 5 s. This figure represents the "raw data" that includes a background level (corresponding to the dark noise of the APD array of the MPPC device).
As this noise level is constant when averaged over a period of 0.1 s (1000 data points with 0.1 ms time interval between successive data points) or longer, it is possible to subtract the average noise level from the raw data to generate the true amplitude of the received intensity signal (in counts). An average, formed over the first 1000 data points of Fig. 3(a) was determined to be 1.54 counts. This value was subtracted from all data points of Fig. 3(a) to give the data with background subtracted and is presented in (b).
The pink trace in Fig. 3(b) corresponds to the 1000 point moving average imposed on the data with background removed (the blue trace in Fig. 3(b) ). During the time periods of 20 s when radiation was delivered to the sensor, an average value (corresponding to a value of 24 counts) was observed and this remains constant throughout the irradiation period in the case of both pulses. The signal to noise ratio at the detector, and the required 1000 point moving average filter, indicates that the current resolution (lowest detectable level) of the sensor is 1 MU.
The data of Fig. 3 (b) were used to calculate the cumulative dose as it was recorded by the sensor. This was undertaken by integrating the averaged dose value on a point by point basis. The characteristic showing the accumulated dose resulting from Fig. 3(b) is shown in Fig. 4 .
The results of Fig. 4 show the expected linear increase of dose measured by the OFS during the application of the irradiation in two consecutive macro-pulses (as shown in Fig. 3(b) ) from the linac. The linear increase is in evidence during both macropulses and the accumulated dose is identical in each case in terms of the rate of increase (2.79 × 10 5 counts per sec) and final values (5.577 × 10 6 counts for macro-Pulse 1 and 11.154 × 10 counts for macro-Pulse 2). The IC was capable of recording the dose levels accumulated during the application and was calibrated to indicate these values in MUs. In the case of Fig. 4 the values recorded on the IC at the end of each pulse were 204 and 408 MUs for macro-Pulse 1 and 2, respectively. These values were recorded manually in the clinic and this was performed for all tests undertaken in this work. The excellent time resolution of the MPPC detector (0.1 ms gate time) has meant that the data captured using the device allows the individual X-Ray micro-pulses of the linac to be detected. The pattern of micro-pulse delivery over a time period of 0.1 s was selected and recorded at an arbitrarily selected time of approximately 10 s, which ensures that the recording period fully coincided with the active beam delivery phase of macropulse 1. The 0.1 s integration period was chosen to ensure that a sufficient number of micro-pulses would be captured to form a true mean value of the amplitude and corresponds to the integration time of previously obtained results using an Ocean Optics QE9600 spectrometer as reported by McCarthy et al. [19] . This was repeated for a number of irradiation cycles recorded in the same manner as Fig. 3 , but for which the dose rate was varied from 600 MU/min (as in Fig. 3 ) to 100 MU/min in steps of 100 MU/min. All other operating conditions were maintained as in Fig. 3 and the data were captured and analysed in the same way as Fig. 3 does not change their average amplitude. It is reported that the linac exhibits some overshoot in its initial delivery of radiation, which is then compensated for through a variation in radiation over the remainder of the prescribed radiation dose [21] . This accounts for some of the fluctuations in amplitude observed in the micro-pulses of Figs. 5(b) to 10(b) but it is unclear at this point whether the limited sampling period (limited by the gate time of the MPPC to 0.1 ms) may also contribute to this as an artefact in the measurement. A reduction of the gate time to 1 μs, together with adequate light detection capability, may confirm this, but this is currently not achievable using the current state of the art in detector technology.
However, it is clear from Figs. 5(b) to 10(b) that it is the number of individual micro-pulses in the 0.1 s time window that is the prime factor in determining the average value of the dose rate over the entire macro-pulse duration (the pink line in each of the records 5(a) to 10(a)) and not any fluctuation in micropulse height. If the number of complete micro-pulses captured in each frame in 5(b) to 10(b) is counted and the value compared against the moving average amplitude in each of Figs. 5(a) to 10(a), the following table (see Table I ) can be constructed.
The data contained in Table I clearly demonstrate that there is a linear relationship between the number of complete micropulses captured in a 0.1 s window and the dose rate. Also the number of micro-pulses is always a multiple of 6 with the maximum being 36 and the minimum being 6. This represents a pulse rate of 60-360 pulses per second (pps) or to a pulse repetition rate (frequency) in the range 60-360 Hz. Since their initial appearance as clinical instruments in the early 1970s to the present day, medical linacs are almost always operated with an output beam micro-pulse of duration of 1-5 μs and repetition frequencies of 5-500 pps [22] [23] [24] . Medical linacs have an integrated dose rate servo (DRS) used to ensure a steady dose rate. One type of DRS, used in some Varian machines is the pulse drop servo [25] , which as the name suggests, drops individual micro-pulses as a means of regulating the dose rate. This process is evident when comparing the time-resolved pulses for 600 MU/min (see Table Iis also plotted versus dose rate in Fig. 11 . Fig. 11 clearly shows that Fig. 11 . The variation of averaged Linac pulse amplitude (intensity) as measured using the OFS versus dose rate. OFS data captured from Figs. 5-10. there is excellent linearity between the average amplitude as measured by the OFS and the dose rate delivered by the linac. A linear regression analysis shows that the R 2 value in this case is 0.9999. Also the intercept is very close to the (0, 0) point, the y axis intercept being at (0, 0.133). This corresponds to a value of 0.5% of the maximum value on the y axis (intensity counts).
The result of Fig. 11 shows conclusively that although the amplitude of the individual micro-pulses of X-Ray irradiation delivered by the linac may fluctuate, if the amplitude data is averaged over a sufficiently long interval (in this case 0.1 s) the fluctuations are insignificant and the averaged amplitude value reflects the dose rate with a high degree of accuracy and linearity.
Having identified the mode of radiation delivery in pulse form, it is essential that the OFS is able to accurately measure dose, especially if its intended use is a real time dosimeter for clinical applications. For this reason, the IC was included so that simultaneous dose measurements could be recoded as described earlier (in Section II) and as shown photographically in Fig. 2(b) . The IC was able to provide a single figure of accumulated dose at the end of each macro-pulse (in Figs. 5-10) . A time resolved dose profile similar to that shown in Fig. 4 was constructed for each case of the dose rate (corresponding to Figs. 5(a) to 10(a)) and the accumulated dose at the end of each macro-pulse was recorded for each value of dose rate. Using these characteristics it was possible to construct an output intensity count versus dose characteristic for each dose rate case. The results of this analysis are shown in Fig. 12 .
From Fig. 12 it is clear that there is an excellent linear relationship between the dose measured by the OFS and the "true dose" as measured by the IC. The R2 value in this case was 0.9995 and the line crosses the y axis at a count value of −8552.6. The latter expressed as a fraction of the maximum count value is −8552.6/5577408 = −1.5 × 10 −3 (−0.15%), i.e., very close to zero. A comparison between the integrated accumulated dose measured using the OFS and corresponding data using the reference standard IC for the dose rate range 600 to 100 MU/min shows that there is a statistical variation in the dose delivered between the two macro-pulses for the same dose rate, with the percentage variance being between 0% and 0.59% for the IC and 0.02% and 0.29% for the OFS. This is consistent with the Fig. 12 . The variation of the accumulated integrated dose after 120 s pulse of radiation with measured dose rate using the commercial IC for dose rates in the range 100 to 600 MU/min. OFS data derived from Figs. 5-10. specifications of modern day linacs. Although it would have been favourable to have more data points in determining the variance in measurement, time for data acquisition at the clinic was limited and so two pulses per record was established as the standard protocol for testing. Future testing will incorporate more data measurements to provide a more accurate measurement of reliability.
IV. CONCLUSION
Measurements of the pulsed X-Ray output of a Radiotherapy clinic based Linac have been conducted in real-time using a scintillator based OFS. The novel measurements have indicated that the Linac alters the micro-pulse sequence to give effective pulse repetition rates between 60 to 360 pps and it is this that is used to determine the dose rate of the delivered radiotherapy beam. Averaging the amplitude of the recorded micro-pulses using 1000 point moving average filter also confirms that the amplitude of the averaged pulse of the detected light intensity of the OFS very closely matches that of the dose rate setting on the linac. A linear regression analysis comparing these two quantities has confirmed this to be a highly linear relationship with an R 2 value of 0.9999 and an offset from the (0, 0) coordinate 0.5% of the maximum value on the y axis (intensity counts). Furthermore, measurements of accumulated dose using the OFS have demonstrated that it is also capable of highly linear measurement (R 2 of 0.9995) when calibrated against simultaneous measurements of dose recorded using a co-located IC for a wide range of dose rates (100 to 600 MU/min).
It is clear therefore that the novel optical fibre based sensor of this investigation is capable of accurate real time dose measurement for a wide range of operating conditions in clinical EBRT.
